Source: Annual Congress 2005 - Advances in noninvasive monitoring of airway inflammation and obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Roy, Z. Borrill, C. Starkey, J. Vestbo, D. Singh (Manchester, United Kingdom). Hyperinflation is associated with reduced nitric oxide production in COPD. Eur Respir J 2005; 26: Suppl. 49, 1455

Member's Comments

No comment yet.

Related content which might interest you: Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Alveolar nitric oxide is increased in uncontrolled asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Salbutamol temporarily increases the bronchial production of nitric oxide Source: Eur Respir J 2007; 30: Suppl. 51, 63s Year: 2007 Fractional exhaled nitric oxide is associated with more severe asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Increased nitric oxide production by neutrophils in bronchial asthma Source: Eur Respir J 2001; 17: 868-871 Year: 2001 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Nocturnal symptoms in asthma are related to increased alveolar nitric oxide concentration Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002 Clinical correlates of alveolar nitric oxide in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD Source: Eur Respir J, 51 (1) 1701457; 10.1183/13993003.01457-2017 Year: 2018 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Smoking decreases bronchial nitric oxide output Source: Eur Respir J 2005; 26: Suppl. 49, 152s Year: 2005 Acinar and bronchial nitric oxide levels in stable and exacerbated COPD. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Exhaled nitric oxide in asthma Source: Eur Respir Monogr 2010; 49: 32-44 Year: 2010 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Who are the children with increased faractional exhaled nitric oxide? Source: Virtual Congress 2020 – Paediatric asthma Year: 2020